BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37259348)

  • 1. BET Bromodomain Degradation Disrupts Function but Not 3D Formation of RNA Pol2 Clusters.
    Chin DH; Osman I; Porch J; Kim H; Buck KK; Rodriguez J; Carapia B; Yan D; Moura SB; Sperry J; Nakashima J; Altman K; Altman D; Gryder BE
    Pharmaceuticals (Basel); 2023 Jan; 16(2):. PubMed ID: 37259348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAX3-FOXO1 Establishes Myogenic Super Enhancers and Confers BET Bromodomain Vulnerability.
    Gryder BE; Yohe ME; Chou HC; Zhang X; Marques J; Wachtel M; Schaefer B; Sen N; Song Y; Gualtieri A; Pomella S; Rota R; Cleveland A; Wen X; Sindiri S; Wei JS; Barr FG; Das S; Andresson T; Guha R; Lal-Nag M; Ferrer M; Shern JF; Zhao K; Thomas CJ; Khan J
    Cancer Discov; 2017 Aug; 7(8):884-899. PubMed ID: 28446439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PAX3-FOXO1 uses its activation domain to recruit CBP/P300 and shape RNA Pol2 cluster distribution.
    Asante Y; Benischke K; Osman I; Ngo QA; Wurth J; Laubscher D; Kim H; Udhayakumar B; Khan MIH; Chin DH; Porch J; Chakraborty M; Sallari R; Delattre O; Zaidi S; Morice S; Surdez D; Danielli SG; Schäfer BW; Gryder BE; Wachtel M
    Nat Commun; 2023 Dec; 14(1):8361. PubMed ID: 38102136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PAX3-FOXO1 dictates myogenic reprogramming and rhabdomyosarcoma identity in endothelial progenitors.
    Searcy MB; Larsen RK; Stevens BT; Zhang Y; Jin H; Drummond CJ; Langdon CG; Gadek KE; Vuong K; Reed KB; Garcia MR; Xu B; Kimbrough DW; Adkins GE; Djekidel N; Porter SN; Schreiner PA; Pruett-Miller SM; Abraham BJ; Rehg JE; Hatley ME
    Nat Commun; 2023 Nov; 14(1):7291. PubMed ID: 37968277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXF1 is required for the oncogenic properties of PAX3-FOXO1 in rhabdomyosarcoma.
    Milewski D; Shukla S; Gryder BE; Pradhan A; Donovan J; Sudha P; Vallabh S; Pyros A; Xu Y; Barski A; Szabo S; Turpin B; Pressey JG; Millay DP; Khan J; Kalinichenko VV; Kalin TV
    Oncogene; 2021 Mar; 40(12):2182-2199. PubMed ID: 33627785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PAX3-FOXO1 drives miR-486-5p and represses miR-221 contributing to pathogenesis of alveolar rhabdomyosarcoma.
    Hanna JA; Garcia MR; Lardennois A; Leavey PJ; Maglic D; Fagnan A; Go JC; Roach J; Wang YD; Finkelstein D; Hatley ME
    Oncogene; 2018 Apr; 37(15):1991-2007. PubMed ID: 29367756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KDM3A/Ets1 epigenetic axis contributes to PAX3/FOXO1-driven and independent disease-promoting gene expression in fusion-positive Rhabdomyosarcoma.
    Sobral LM; Hicks HM; Parrish JK; McCann TS; Hsieh J; Goodspeed A; Costello JC; Black JC; Jedlicka P
    Mol Oncol; 2020 Oct; 14(10):2471-2486. PubMed ID: 32697014
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Nord JA; Wynia-Smith SL; Gehant AL; Jones Lipinski RA; Naatz A; Rioja I; Prinjha RK; Corbett JA; Smith BC
    Front Endocrinol (Lausanne); 2022; 13():923925. PubMed ID: 36176467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inhibition of the BD2 bromodomain of BET proteins in prostate cancer.
    Faivre EJ; McDaniel KF; Albert DH; Mantena SR; Plotnik JP; Wilcox D; Zhang L; Bui MH; Sheppard GS; Wang L; Sehgal V; Lin X; Huang X; Lu X; Uziel T; Hessler P; Lam LT; Bellin RJ; Mehta G; Fidanze S; Pratt JK; Liu D; Hasvold LA; Sun C; Panchal SC; Nicolette JJ; Fossey SL; Park CH; Longenecker K; Bigelow L; Torrent M; Rosenberg SH; Kati WM; Shen Y
    Nature; 2020 Feb; 578(7794):306-310. PubMed ID: 31969702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of BET Family Proteins Suppresses African Swine Fever Virus Infection.
    Zhao Y; Niu Q; Yang S; Yang J; Zhang Z; Geng S; Fan J; Liu Z; Guan G; Liu Z; Zhou J; Hu H; Luo J; Yin H
    Microbiol Spectr; 2022 Aug; 10(4):e0241921. PubMed ID: 35758684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting MYCN-Driven Transcription By BET-Bromodomain Inhibition.
    Henssen A; Althoff K; Odersky A; Beckers A; Koche R; Speleman F; Schäfers S; Bell E; Nortmeyer M; Westermann F; De Preter K; Florin A; Heukamp L; Spruessel A; Astrahanseff K; Lindner S; Sadowski N; Schramm A; Astorgues-Xerri L; Riveiro ME; Eggert A; Cvitkovic E; Schulte JH
    Clin Cancer Res; 2016 May; 22(10):2470-81. PubMed ID: 26631615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negative correlation of single-cell
    Regina C; Hamed E; Andrieux G; Angenendt S; Schneider M; Ku M; Follo M; Wachtel M; Ke E; Kikuchi K; Henssen AG; Schäfer BW; Boerries M; Wagers AJ; Keller C; Hettmer S
    Life Sci Alliance; 2021 Sep; 4(9):. PubMed ID: 34187933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Affinity map of bromodomain protein 4 (BRD4) interactions with the histone H4 tail and the small molecule inhibitor JQ1.
    Jung M; Philpott M; Müller S; Schulze J; Badock V; Eberspächer U; Moosmayer D; Bader B; Schmees N; Fernández-Montalván A; Haendler B
    J Biol Chem; 2014 Mar; 289(13):9304-19. PubMed ID: 24497639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BET Family Protein BRD4: An Emerging Actor in NFκB Signaling in Inflammation and Cancer.
    Hajmirza A; Emadali A; Gauthier A; Casasnovas O; Gressin R; Callanan MB
    Biomedicines; 2018 Feb; 6(1):. PubMed ID: 29415456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Super-enhancers and the super-enhancer reader BRD4: tumorigenic factors and therapeutic targets.
    Qian H; Zhu M; Tan X; Zhang Y; Liu X; Yang L
    Cell Death Discov; 2023 Dec; 9(1):470. PubMed ID: 38135679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of an N-Terminal BRD4 Bromodomain-Targeted Degrader.
    Divakaran A; Scholtz CR; Zahid H; Lin W; Griffith EC; Lee RE; Chen T; Harki DA; Pomerantz WCK
    ACS Med Chem Lett; 2022 Oct; 13(10):1621-1627. PubMed ID: 36262390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRD4 assists elongation of both coding and enhancer RNAs by interacting with acetylated histones.
    Kanno T; Kanno Y; LeRoy G; Campos E; Sun HW; Brooks SR; Vahedi G; Heightman TD; Garcia BA; Reinberg D; Siebenlist U; O'Shea JJ; Ozato K
    Nat Struct Mol Biol; 2014 Dec; 21(12):1047-57. PubMed ID: 25383670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of target genes of PAX3-FOXO1 in alveolar rhabdomyosarcoma.
    Ahn EH; Mercado GE; Laé M; Ladanyi M
    Oncol Rep; 2013 Aug; 30(2):968-78. PubMed ID: 23733015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BET proteins are essential for the specification and maintenance of the epiblast lineage in mouse preimplantation embryos.
    Tsume-Kajioka M; Kimura-Yoshida C; Mochida K; Ueda Y; Matsuo I
    BMC Biol; 2022 Mar; 20(1):64. PubMed ID: 35264162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BET bromodomain proteins regulate enhancer function during adipogenesis.
    Brown JD; Feldman ZB; Doherty SP; Reyes JM; Rahl PB; Lin CY; Sheng Q; Duan Q; Federation AJ; Kung AL; Haldar SM; Young RA; Plutzky J; Bradner JE
    Proc Natl Acad Sci U S A; 2018 Feb; 115(9):2144-2149. PubMed ID: 29444854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.